Major adverse cardiac and cerebrovascular events · people with or without existing CVD, men and women
It is very uncertain whether higher polyunsaturated fatty acid (PUFA) changes major adverse cardiac and cerebrovascular events compared with lower PUFA (very low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): cardiac blocks (high‐degree atrioventricular block and bundle) · patients with myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): cardiac blocks… compared with disopyramide (very low certainty).
1 finding from 1 review
Adverse events · people at high risk of or withcardiovascular disease
Mindfulness‐based interventions (MBIs) showed no clear difference in adverse events compared with non‐active comparators (low certainty).
1 finding from 1 review
Adverse events · people at high risk of or withcardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people at high risk of or withcardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people at high risk of or withcardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Adults with coronary heart disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with coronary disease, ischaemic cerebrovascular disease, peripheral arterial disease or at high risk of atherothrombotic disease
1 finding from 1 review
Intervention not reported
Adverse events ‐ myopathy · people with cardiovascular disease or at high risk of cardiovascular disease
It is very uncertain whether the intervention changes adverse events ‐ myopathy (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ hepatopathy · people with cardiovascular disease or at high risk of cardiovascular disease
The intervention showed no clear difference in adverse events ‐ hepatopathy (low certainty).
1 finding from 1 review
Adverse eventsMeasurement unclear · overweight or obese adults
1 finding from 1 review
Intervention not reported
Major adverse cardiovascular events (MACE) · people with cardiovascular disease or at high risk of cardiovascular disease
The intervention probably leads to lower major adverse cardiovascular events (MACE) (moderate certainty).
1 finding from 1 review